drugset / Trial / NCT01291173

Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder

NCT01291173

Phase 2 Completed 271 enrolled Shire
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy of SPD489 compared to placebo in the treatment of moderate to severe binge eating disorder as measured by the number of binge days per week

Timeline

Start
2011-05-10
Primary completion
2012-01-30
Completion
2012-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lisdexamfetamine Other / unclassified 30 mg
Subject Lisdexamfetamine Other / unclassified 50 mg
Subject Lisdexamfetamine Other / unclassified 70 mg

Indications